StudyFinder
The efficacy of incobotulinum toxin A injections for treatment of tinnitus: a randomized controlled trial
Recruiting
This study is a double blinded crossover clinical trial evaluating the safety and effectiveness of incobotulinum toxin A or a placebo (before crossover) injections for the treatment of tinnitus.
18 years and over
Inclusion Criteria:
• unilateral or bilateral tinnitus present for at least 2 months
• score greater than 16 on the Tinnitus Handicap Inventory
Exclusion Criteria:
• known hypersensitivity to any botulinum toxin product
• received botulinum toxin for any medical reason in the past 4 months
• infection at proposed injection sites
• scheduled for neurological or otological surgery
• significant psychiatric history or associated diagnosis of major depression
• pregnant or breast feeding
Ear, Nose & Throat
Tinnitus
Stephanie Standal - stan0621@umn.edu
Stephanie Standal
STUDY00011665
32272